Toll-like receptor 3 and geographic atrophy in age-related macular degeneration

New England Journal of Medicine

Volumn 359, Issue 14, 2008, Pages 1456-1463

  Yang, Zhenglin ^a,b,g   Stratton, Charity ^b   Francis, Peter J ^c   Kleinman, Mark E ^d   Tan, Perciliz L ^e   Gibbs, Daniel ^b   Tong, Zongzhong ^b   Chen, Haoyu ^b,g   Constantine, Ryan ^b   Yang, Xian ^b,g   Chen, Yuhong ^b,g   Zeng, Jiexi ^b,g   Davey, Lisa ^e   Ma, Xiang ^b   Hau, Vincent S ^b   Wang, Chi ^d   Harmon, Jennifer ^b   Buehler, Jeanette ^b   Pearson, Erik ^b   Patel, Shrena ^b   Kaminoh, Yuuki ^b   Watkins, Scott ^b   Luo, Ling ^b   Zabriskie, Norman A ^b   Bernstein, Paul S ^b   Cho, Wongil ^e   Schwager, Andrea ^b   Hinton, David R ^h   Klein, Michael L ^c   Hamon, Sara C ⁱ   Simmons, Emily ^c   Yu, Beifeng ^b   Campochiaro, Betsy ^e   Sunness, Janet S ^e,f   Campochiaro, Peter ^e   Jorde, Lynn ^b   Parmigiani, Giovanni ^e   Zack, Donald J ^e   Katsanis, Nicholas ^e,l   Ambati, Jayakrishna ^d   Zhang, Kang ^b,g,j,k   more..

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f GREATER BALTIMORE MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ ROCKEFELLER UNIVERSITY   (United States)

^j PEKING UNIVERSITY   (China)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LEUCINE; PHENYLALANINE; TOLL LIKE RECEPTOR 3; INTERFERON INDUCING AGENT; POLYINOSINIC POLYCYTIDYLIC ACID; TLR3 PROTEIN, HUMAN; TLR3 PROTEIN, MOUSE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATROPHY; CONTROLLED STUDY; EPITHELIUM CELL; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OPHTHALMOSCOPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CASE CONTROL STUDY; CLINICAL TRIAL; CYTOLOGY; DRUG EFFECT; GENETICS; IN VITRO STUDY; MOUSE MUTANT; MULTICENTER STUDY; PATHOLOGY; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; APOPTOSIS; CASE-CONTROL STUDIES; CHOROIDAL NEOVASCULARIZATION; GENOTYPE; HUMANS; INTERFERON INDUCERS; MACULA LUTEA; MACULAR DEGENERATION; MICE; MICE, KNOCKOUT; PIGMENT EPITHELIUM OF EYE; POLY I-C; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 3;

EID: 54849148000     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0802437     Document Type: Article

References (39)

1. Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-2.
2. Green WR, Key SN III. Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc 1977;75:180-254.
3. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 1988;2:552-77.
4. Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007;357:553-61.
5. Cameron DJ, Yang Z, Gibbs D, et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 2007;6:1122-5.
6. Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006;314:992-3.
7. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-4.
8. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005;102:7227-32.
9. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-21.
10. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006;38:1173-7. [Erratum, Nat Genet 2007;39:567.]
11. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.
12. Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006;314:989-92.
13. Magnusson KP, Duan S, Sigurdsson H, et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006;3(1):e5.
14. Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006;38:1055-9.
15. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005;14:3227-36.
16. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005;77:389-407.
17. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006;38:458-62.
18. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 2007;39:1200-1.
19. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48:257-93.
20. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006;51:137-52.
21. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-8.
22. Zareparsi S, Buraczynska M, Branham KE, et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005;14:1449-55.
23. Schröder M, Bowie AG. TLR3 in antiviral immunity: key player or bystander? Trends Immunol 2005;26:462-8.
24. Abramson JH, Gahlinger PM. Computer programs for epidemiologists: PEPI version 4.0. Salt Lake City: Sagebrush Press, 2001.
25. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
26. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
27. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 2004;36:512-7.
28. McLellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-57.
29. O'Brien E, Zenger R, Jorde LB. Genetic structure of the Utah Mormons: a comparison of kinship estimates from DNA blood groups, genealogies, and ancestral arrays. Am J Hum Biol 1996;8:609-14.
30. O'Brien E, Rogers AR, Beesley J, Jorde LB. Genetic structure of the Utah Mormons: comparison of results based on RFLPs, blood groups, migration matrices, isonymy, and pedigrees. Hum Biol 1994;66:743-59.
31. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-8.
32. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43-50. [Erratum, Nature 1998;393:396.]
33. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89:175-84.
34. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998;391:96-9.
35. Karikó K, Bhuyan P, Capodici J, Weissman D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 2004;172:6545-9.
36. Kleinman ME, Yamada K, Takeda A, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Naure 2008;452:591-7.
37. Gitlin L, Barchet W, Gilfillan S, et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytid ylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006;103:8459-64.
38. Yang YL, Reis LF, Pavlovic J, et al. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 1995;14:6095-106.
39. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-7.